(Q34560068)

English

Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis (English)

1 reference

Europe PubMed Central

3 August 2017

steatohepatitis

0 references

1 reference

based on heuristic

inferred from title

author name string

Sajjad A

1

1 reference

Europe PubMed Central

3 August 2017

Mottershead M

2

1 reference

Europe PubMed Central

3 August 2017

Syn WK

3

1 reference

Europe PubMed Central

3 August 2017

Jones R

4

1 reference

Europe PubMed Central

3 August 2017

Smith S

5

1 reference

Europe PubMed Central

3 August 2017

Nwokolo CU

6

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

1 August 2005

1 reference

Europe PubMed Central

3 August 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

3 August 2017

22

1 reference

Europe PubMed Central

3 August 2017

291-299

1 reference

Europe PubMed Central

3 August 2017

4

1 reference

Europe PubMed Central

3 August 2017

Nonalcoholic steatohepatitis: what we know in the new millennium

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02562.X

21 January 2018

Association of nonalcoholic fatty liver disease with insulin resistance.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02562.X

21 January 2018

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02562.X

21 January 2018

Pathogenesis of steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02562.X

21 January 2018

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02562.X

21 January 2018

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02562.X

21 January 2018

Effect of alcohol consumption on the gut.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02562.X

21 January 2018

Ghrelin enhances appetite and increases food intake in humans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02562.X

21 January 2018

Upregulation of Ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02562.X

21 January 2018

Low ghrelin concentrations in nonalcoholic fatty liver disease are related to insulin resistance.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02562.X

21 January 2018

Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02562.X

21 January 2018

Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02562.X

21 January 2018

Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02562.X

21 January 2018

Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02562.X

21 January 2018

Ghrelin, an orexigenic signaling molecule from the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02562.X

21 January 2018

Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02562.X

21 January 2018

Plasma ghrelin following cure of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02562.X

21 January 2018

Balance in ghrelin and leptin plasma levels in anorexia nervosa patients and constitutionally thin women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02562.X

21 January 2018

Effects of modified sham feeding on ghrelin levels in healthy human subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02562.X

21 January 2018

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02562.X

21 January 2018

Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02562.X

21 January 2018

Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02562.X

21 January 2018

TNF-alpha and insulin resistance: summary and future prospects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02562.X

21 January 2018

Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02562.X

21 January 2018

Hyperglycaemia suppresses the secretion of ghrelin, a novel growth-hormone-releasing peptide: responses to the intravenous and oral administration of glucose

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02562.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2005.02562.X

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34560068&oldid=1946501413"